OAS1 and COVID-19: Still, the severity of viral disease [29,77] seems to be increasingly linked to variability in the repertoires of expressed ISGs as evidenced by isoforms of OAS1 as well as OAS1 loss-of function alleles associated with distinct outcomes in COVID-19 patients.